CorMedix (CRMD) Reports Q2 Loss, Tops Revenue Estimates
CRMDCorMedix(CRMD) ZACKS·2024-08-14 21:45

CorMedix (CRMD) came out with a quarterly loss of 0.25pershareversustheZacksConsensusEstimateofalossof0.25 per share versus the Zacks Consensus Estimate of a loss of 0.26. This compares to loss of 0.25pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof3.850.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.85%. A quarter ago, it was expected that this pharmaceutical and medical device company would post a loss of 0.27 per share when it actually produced a loss of $0.25, delivering a surprise of 7.41%.Over the last four quarters, ...